ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,867.08
-0.09%
US Tech 100
20,312.00
-1.24%
Dow Jones
42,342.24
0.04%
Brent Oil
71.765
-0.86%
Bitcoin
93,437.73
-4.13%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Channel Therapeutics Corporation (CHRO) Quote

Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

AMEX
0.653
0.063
(10.68%)
Closed December 19 4:00PM
Delayed by 15 minutes
0.653
0.00
( 0.00% )
Pre Market: 4:25AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.653
Bid
-
Ask
-
Volume
1,300
0.00 Day's Range 0.00
0.45 52 Week Range 6.00
Market Cap
3.936M
Previous Close
0.653
Open
-
Last Trade
100
@
0.653
(formt)
Last Trade Time
04:25:19
Financial Volume
-
VWAP
-
Average Volume (3m)
161,435
Shares Outstanding
6,028,011
Dividend Yield
-
PE Ratio
-0.53
Earnings Per Share (EPS)
-1.22
Revenue
-
Net Profit
-7.38M

About Channel Therapeutics Corporation

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
channeltherapeutics.com
Headquarters
Reno, Nevada, USA
Founded
-
Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was $0.65. Over the last year, Channel Therapeutics shares have traded in a share price range of $ 0.45 to $ 6.00.

Channel Therapeutics currently has 6,028,011 shares outstanding. The market capitalization of Channel Therapeutics is $3.94 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.53.

Ask ADVFN Intelligence (AI)

CHRO Latest News

More News

Chromocell Announces Amendment to Stock Repurchase Plan

FREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

October 24 2024
GlobeNewswire Inc.

Chromocell to Participate in the Virtual Investor Lunch Break Series

FREEHOLD, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

July 15 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

May 15 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15 2024
Edgar (US Regulatory)

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

FREEHOLD, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

May 13 2024
GlobeNewswire Inc.

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

April 09 2024
GlobeNewswire Inc.

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

March 21 2024
GlobeNewswire Inc.

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

FREEHOLD, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...

March 18 2024
GlobeNewswire Inc.

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment...

March 11 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0364-5.279953582830.68940.68940.56332102990.59961457CS
40.0345.492730210020.6190.880.55131638560.6990816CS
12-0.3169-32.67347149190.96991.040.451614350.73252942CS
26-0.757-53.68794326241.411.750.45996750.80642223CS
52-5.347-89.1166666667660.45691291.06548021CS
156-5.347-89.1166666667660.45691291.06548021CS
260-5.347-89.1166666667660.45691291.06548021CS

CHRO - Frequently Asked Questions (FAQ)

What is the current Channel Therapeutics share price?
The current share price of Channel Therapeutics is $ 0.653
How many Channel Therapeutics shares are in issue?
Channel Therapeutics has 6,028,011 shares in issue
What is the market cap of Channel Therapeutics?
The market capitalisation of Channel Therapeutics is USD 3.94M
What is the 1 year trading range for Channel Therapeutics share price?
Channel Therapeutics has traded in the range of $ 0.45 to $ 6.00 during the past year
What is the PE ratio of Channel Therapeutics?
The price to earnings ratio of Channel Therapeutics is -0.53
What is the reporting currency for Channel Therapeutics?
Channel Therapeutics reports financial results in USD
What is the latest annual profit for Channel Therapeutics?
The latest annual profit of Channel Therapeutics is USD -7.38M
What is the registered address of Channel Therapeutics?
The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the Channel Therapeutics website address?
The website address for Channel Therapeutics is channeltherapeutics.com
Which industry sector does Channel Therapeutics operate in?
Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LLYXDefiance Daily Target 2X Long LLY ETF
$ 21.10
(19.95%)
27.97k
GPUSHyperscale Data Inc
$ 6.24
(16.64%)
105
EPVProShares UltraShort FTSE Europe
$ 47.06
(12.38%)
57
KNWKnow Labs Inc
$ 0.1695
(12.03%)
5.07k
ETHDProshares Ultrashort Ether ETF
$ 24.80
(11.56%)
46.08k
NVOXDefiance Daily Target 2x Long Nvo ETF
$ 10.17
(-43.42%)
20.08k
OGENOragenics Inc
$ 0.3166
(-15.80%)
92.6k
TPETTrio Petroleum Corp
$ 1.25
(-14.97%)
172.62k
BHBBar Harbor Bankshares
$ 28.00
(-11.20%)
325
ETHU2x Ether ETF
$ 7.24
(-11.06%)
6.2M
ETHU2x Ether ETF
$ 7.24
(-11.06%)
6.2M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 2.50
(10.13%)
5.45M
MSTUT Rex 2X Long MSTR Daily Target ETF
$ 9.12
(-10.32%)
4.49M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 24.90
(-5.32%)
4.16M
UVIX2x Long VIX Futures ETF
$ 5.62
(4.07%)
2.1M

Discussion

View Full Feed
dalesio_98 dalesio_98 3 minutes ago
Respond to yourself much.

O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo

Good luck to All!
flipper44 flipper44 4 minutes ago
Hmm.

12/14 Soft Bash from seeking alpha (Saturday)
12/16 Soft Bash from Trading alpha (Mon b/4 opening) (screaming more dilutions)
12/17 Scotty screams more dilutions (hadn’t been one since 12/12)
12/18 Fake 8,000,000 outstanding share dilution was only 800,000.
NWBO
JJZander JJZander 4 minutes ago
News  style="caret-color: rgb(68, 68, 68); color: rgba(68, 68, 68, 1); font-family: "Nunito Sans", Helvetica, Arial, sans-serif; font-size: 1.1em; font-weight: 700"4Cable TV International, Inc. Eliminates $500,000 in Debt, Targets $1.25 Million in 60 Days, and Advances Revenue Initiatives with Genet
CATV
pinkslipjunkie pinkslipjunkie 4 minutes ago
Yes but I think that was done a year ago

Paradigm Oil And Gas, Inc. Announces Change in Control and Letter of Intent
https://www.otcmarkets.com/otcapi/company/dns/news/document/71755/content
PDGO
weedtrader420 weedtrader420 4 minutes ago
This is a crushing dip, but it’s all gonna come back up real quick.
XRPUSD
JJZander JJZander 4 minutes ago
CATV  style="caret-color: rgb(68, 68, 68); color: rgba(68, 68, 68, 1); font-family: "Nunito Sans", Helvetica, Arial, sans-serif; font-size: 1.1em; font-weight: 700"4Cable TV International, Inc. Eliminates $500,000 in Debt, Targets $1.25 Million in 60 Days, and Advances Revenue Initiatives with Genet
Risk vs Reward Risk vs Reward 5 minutes ago
Can't you make it without me ? I'll post when there's something that merits it. Unfortunately your not it. 
KULR
primecomm primecomm 5 minutes ago
$TNXP Explosion Imminent $$$
TNXP
primecomm primecomm 5 minutes ago
Good Morning $TNXP
TNXP
Ranb2khz Ranb2khz 6 minutes ago
Show It

“If you are wise and understand God’s ways, prove it by living an honorable [good] life, doing good works with the humility that comes from wisdom.” ~ James 3:13

Life demands a list of questions be answered:

• Whom will you serve?
• What wi
weedtrader420 weedtrader420 8 minutes ago
HBAR is nothing without XRP going up
XRPUSD
chereb19 chereb19 8 minutes ago
Read the last 10-Q
RDGL
SkeBallLarry SkeBallLarry 9 minutes ago
" Matt just-may still be in the running w/Trump's backing " .. ??
Moonboy1 Moonboy1 11 minutes ago
What is this thing doing? Are we going up or down?
TNXP
Iggy_Bot Iggy_Bot 11 minutes ago
So the truth comes out about Biden, Dems gonna shut down the Gov tonight, why can't Trump be sworn in today ?
PutzMueler PutzMueler 12 minutes ago
Agree but, we have another week of punishment to endure.

Tax loss season is the only benefit for me now. And it’s not even for claiming a taxation loss. LoL

I can’t wait for 2024 to end.
NB
sab63090 sab63090 13 minutes ago
A couple of interesting things have happened, the Dow Jones has definitely now hit 9 days down according to TD Sequential, I guess 13 to complete...I also noticed that the $SPX break has filled an open gap and broke the 50 day sma, too! Early looks down on a Friday no less...oh oh
SPX
nowwhat2 nowwhat2 13 minutes ago
Gd'eye myte

Yea seems somewhat possible....Cheers

https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=&symb=au%3Aaxe&x=54&y=12&time=100&startdate=1%2F4%2F2017&enddate=1%2F30%2F2025&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=0&maval=9&uf=
QNCCF
rogers711 rogers711 14 minutes ago
That's also not true... 😂 where? 
RDGL
Uncle Monkey Uncle Monkey 14 minutes ago
maybe .00002 by EOY
CBRF
Bull_Dolphin Bull_Dolphin 14 minutes ago
Wouldn't this be fun?

Matt Gaetz Threatens to Reveal Swamp’s #MeToo Deals, Then Exit Stage Left

https://www.rvmnews.com/2024/12/matt-gaetz-threatens-to-reveal-swamps-metoo-deals-then-exit-stage-left/

Your Recent History

AMEX
CHRO
Channel Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads